Sleep Disorders Trial, Recruiting NCT07143266 Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07143266
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with hypothalamic-pituitary dysfunction, meaning a problem affecting the hypothalamus and/or pituitary gland, with at least one hormone that the pituitary is not producing properly, AND at least one sign of damage to the hypothalamus (for example: a condition causing the body to not regulate water properly, severe weight gain, uncontrollable hunger, brain scan results showing hypothalamus damage, a past traumatic brain injury, radiation treatment near the base of the brain, or a brain tumour affecting the hypothalamus).
  • Healthy volunteers whose body weight, age, and sex match those of participants in the patient group.

Who may not be able to join:

  • People whose hormone deficiencies have not been well managed in the past 6 months.
  • People who have started taking new medications that affect mood, thinking, or behaviour in the last 3 months, or who use such medications only occasionally.
  • People with a serious condition affecting the liver, lungs, kidneys, or heart.
  • People with a neurological condition that affects how the brain works, such as a history of stroke, dementia, or epilepsy that is not well controlled and has involved recent seizures.
  • People with diabetes that is not well controlled.
  • People currently experiencing active psychosis (a serious mental health episode involving a loss of contact with reality).
  • People with total blindness, glaucoma, uveitis (eye inflammation), vision below a certain level, or who have had eye surgery in the past 6 months.
  • People with any current illness that the trial investigators consider could interfere with taking part safely.
  • People who are pregnant or breastfeeding.
  • People who are unwilling or unable to give written consent to participate.
  • For healthy volunteers only: people who have had a brain or pituitary tumour, radiation treatment involving the hypothalamus or pituitary gland, or a history of reduced pituitary function.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anna Aulinas, MD PhD, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phone: +34932919000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Prevalence of sleep disorders in patients with hypothalamic and pituitary damage compared to healthy controls

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov